Hub On AGORACOM / Corporate Profile / Corporate Website
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
Agoracom Blog Home
Author Archive
Next Gen Discusses Entrance to the Explosive Medical Marijuana Industry
Posted by
at 8:22 AM on Monday, March 24th, 2014
Lexaria Intends to Complete a $2,250,000 Financing
Posted by
at 8:16 AM on Monday, March 24th, 2014
Kelowna, British Columbia–(March 24, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) reports its intention to complete a non-brokered private placement financing, consisting of 5,000,000 Equity Units at US $0.45 per unit, to raise gross proceeds of up to US $2,250,000 (the “Private Placement”).
Each equity unit will consist of one common share of the Company and one non-transferable share purchase warrant, each warrant entitling the holder to purchase one additional common share of the Company for a period of eighteen months from the date of issuance, at a purchase price of US$0.70. The Company may accelerate the expiry date of the warrants if the stock price trades above CAD$1.40 for 20 consecutive days at any time after 6 months and one day has elapsed.
The Company may pay broker commissions of up to 6.0% in cash and 6% in broker warrants in connection with the Private Placement. Each broker’s warrant will be exercisable into one single common share (a “Warrant Shareâ€) at a price of US$0.70 per Warrant Share for a period of eighteen (18) months following closing of the Offering. Certain directors, officers and insiders of the Company may participate in the Private Placement.
The securities issued will be subject to a hold period in Canada of four months and one day, or for any resales into the USA under Rule 144, six months and one day. Proceeds from the equity units will be used for corporate development in the Medical Marijuana business, G&A and general working capital. The Private Placement will be subject to normal regulatory approvals.
The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
About Lexaria
Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.
To learn more about Lexaria Corp. visit www.lexariaenergy.com.
FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business will provide any benefit to Lexaria and no assurance that the proposed financing of up to $2,250,000 will be successful.
The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
Enertopia Announces Corporate Update, Comments on Federal Court Injunction
Posted by
at 7:32 AM on Monday, March 24th, 2014
Vancouver, BC—Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) announces the following Corporate update with respect to the Canadian Federal Court injunction issued Friday March 21. Readers should be advised that the information below is believed to be correct although the case has evolved quickly and may change.
The injunction exempts existing patients currently licensed to possess and grow medical marijuana, from compliance with the new Health Canada regulations for commercial growers that will continue to take effect for those commercial growers, on April 1. The injunction does not affect the new licensing system. The injunction is temporary – for the existing patients, it preserves the status quo only until a legal ruling is produced in their legal case with the government of Canada. News reports suggest that legal case is expected to provide a ruling within one year.
The injunction suggests that Enertopia’s partially-owned partner, The World of Marihuana Productions Ltd, will be allowed to continue to grow for their patients while awaiting for the Health Canada site inspection under the new Marihuana for Medical Purposes Regulations, (MMPR) and for so long as the injunction remains in effect.
The injunction also suggests that Enertopia’s partially-owned partner, The Green Canvas Ltd., will also be allowed to continue to grow for their patients even as they upgrade their facilities to be compliant under the new MMPR system.
The court injunction is good news for medical marihuana patients and the producers that currently supply them. It allows patients access to the medical cannabis they need and allows current producers the ability to meet their patient’s needs, while allowing the current producers to keep their medical marihuana strains.
Health Canada was quoted as saying “While the Courts have said there must be reasonable access to marijuana for medical purposes, Health Canada’s goal is to treat dried marijuana as much as possible like other narcotic drugs used for medical purposes. The Marihuana for Medical Purposes Regulations are intended to provide reasonable access for those Canadians who need access to dried marijuana for medical purposes with the support of a health-care practitioner, while protecting public safety.â€
The Court ruled in favor of the new smaller patient limit as set down in the new (MMPR) regulations with patients being restricted to possessing 150 grams of dried marijuana, which is a limit set by the new (MMPR) regulations.
Health Canada further stated “Health Canada is committed to the implementation of the Marijuana for Medical Purposes Regulations in order to provide Canadians reasonable access to dried marijuana for medical purposes, while protecting public safety.”
“Enertopia believes in the provision of affordable, safe, regulated, high quality medicinal marihuana for all medical marihuana patients not only in Canada but around the World wherever permitted by law. We are seeing daily, the benefits medical cannabis have with helping people regain quality of life. Through no fault of their own – because of disease, work place accidents or automobile accidents – and with the judicious use of medical cannabis as a pain relief medication, many patients have reported relief they have been unable to obtain through any other means. We look forward to complying with and working with Health Canada and all applicable regulations during this period of transition†Stated President Robert McAllister
About Enertopia
Enertopia’s shares are quoted in Canada with symbol TOP in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Dale Paruk, President, Coal Harbor Communications Ltd. at 1.604.662.4505
This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, evaluation of clean energy projects, Oil & Gas Projects, Medical Marihuana Projects  for participation and/or financing, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates.  The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.  There is no assurance that the Company will be successful in completing any anticipated financing and or its joint Venture partners will receive their Health Canada license under the new regulations or any technology will result in future sales.
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
AGORACOM Best Of The Best – March 21, 2014
Posted by
at 6:09 PM on Friday, March 21st, 2014
AGORACOM Founder, George Tsiolis and Chief Market Commentator, Allan Barry Go Via Satellite to discuss and debate Allan’s Best picks this week. George and Allan talk about “PotCom†– the potential explosive growth in small cap medical marijuana stocks that we haven’t seen since “DotCom†but could more likely be compared to the end of prohibition.
Companies included on this week’s show are:
WHY IS JULY 11, 2013 SO IMPORTANT?
Allan and George have already put their viewers well ahead of the game by starting their weekly broadcasts on July 11, 2013 on the thesis that great small-cap companies were so oversold they could not be ignored. One look at the TSX Venture Index proves they hit the nail on the head … but that doesn’t come close to telling the whole story with most of their picks far outperforming an exchange bloated with zombie companies.
Find out which companies Allan and George like this week by watching the video below!
Want to catch up on previous shows?
Weekly “Best Of The Best†Summarizing The Best Picks From Our Daily Shows. Posted Every Friday Afternoon Watch Here
Daily “Small-Cap Breakfast†Where You FIRST Hear Allan’s Picks (Posted Every Day Around 11:00 AM) Watch Live Here
THIS WEEK’S SHOW SPONSORED BY:
$7.7M in February Revenues and +50% In Gross Margins, Virtutone Networks Explains
Posted by
at 4:33 PM on Friday, March 21st, 2014
Virtutone Networks Inc. is a leading supplier of wholesale telecommunication services. The company generated $7.7M in revenue in February 2014 alone and has received accolades by being ranked #1 fastest growing ICT company in Canada 2012 and “Next 50 ICT Companies” in Canada Branham 2013.
FINANCIAL HIGHLIGHTS
- $7.7 million in revenue for February/Â 50% increase in gross margins
- $9.2 million in revenue for January 2014
-
$8.45 million in revenue for December 2013
- $7.2 million in revenue for November 2013
- $3.95 million in revenue for October 2013
Next Gen Announces $2,750,000 Private Placement
Posted by
at 8:34 AM on Friday, March 21st, 2014
Vancouver, British Columbia, Canada – Next Gen Metals Inc., (“Next Gen”, the “Company”) (CSE: N; OTC: NXTTF; Frankfurt: M5BN) is pleased to announce a non-brokered private placement of up to 5,000,000 units for gross proceeds of up to $2,750,000.
Each Unit (“Unit”) at a price of $0.55 per unit will consist of one common share (a “Common Share”) and one-half of one, non-transferrable share purchase warrant (a “Warrant”). Each full Warrant entitles the holder to purchase one Common Share at a price of $0.75 per share for a period of 12 months, subject to accelerated expiry, such expiry being accelerated to 30 days in the event the Company’s shares have closed at or above a price of $1.10 per share for ten consecutive trading days.
The proceeds from the private placement will be used for acquisitions, investments and working capital to advance the company’s initiatives in the Medical Marijuana, Industrial Hemp and Alternative Medicine industries as well as advancing the company’s GreenRush Financial Conference business. The private placement and any finder’s fees payable are subject to regulatory approval. Any securities issued pursuant to the offering shall be subject to a four month and a day hold period commencing on the closing date.
About Next Gen (CSE: N, OTC Pink: NXTTF, FSE: M5BN)
Next Gen is a diversified Canadian public company which focusses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. Recent regulatory/legal changes in North America have provided an opportunity for the company to enter into this emerging multi-billion dollar industry. Next Gen’s vision is to be the leading provider of venture capital, management expertise, education and a facilitator for this explosive new industry. (See press release dated February, 26 2014)
Our business model generates dozens of new business plans and industry related proposals on an ongoing basis. Management continues to receive and review the proposals from various segments of the industry including: alternative medicine, health, food, agri-business, legal grow-ops, technology, client generation, education, public awareness, specialty clinics and ancillary business opportunities. For further information, visit our website at www.nextgenmetalsinc.com.
On March 20, 2014 Next Gen announced that its wholly owned subsidiary GreenRush Financial Conferences (GreenRush), will conduct its first Medical Marijuana, Industrial Hemp and Alternative Medicine business conference in Vancouver on May 7, 2014. The conference will be held at the Vancouver Convention and Exhibition Centre, East, Pan Pacific Hotel, in ballroom A/B/C. GreenRush Financial Conferences will become the platform facilitating investment, education and business to business opportunities across the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. The conferences will feature insightful speakers, government and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, and media representing all aspects of the industry. (See press release dated March 20, 2014).
In light of Next Gen’s vision, Management’s objective is to invest in a basket of companies within this growing industry. The company’s business model continues to generate new business plans and project submittals 24/7.
For further information on GreenRush Financial Conferences please contact us by phone or at [email protected] or [email protected].
For further information on this Private Placement and general Investor Relations Inquiries please contact us by phone or email at [email protected].
Tel: +1 604 685 1870 Fax: +1 604 685 8045 Website: http://www.nextgenmetalsinc.com
650-555 West 12th Avenue, City Square, West Tower, Vancouver, B.C., Canada, V5Z 3X7
On behalf of the Board of Directors
“Harry Barr”
Harry Barr
President & CEO
FORWARD LOOKING INFORMATION
This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements.
Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.
This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
The CSE has neither reviewed nor approved the contents of this News Release.
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
Lexaria Closes $1,272,000 Financing
Posted by
at 8:10 AM on Friday, March 21st, 2014
KELOWNA, BC / Mar 21, 2014 / Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) is pleased to announce it has closed its Private Placement financing announced on March 5 for gross proceeds of $1,272,000. The financing was originally announced for $960,000 but was expanded due to overwhelming demand.
Lexaria will issue 10,600,000 common shares at US$0.12 and 10,600,000 full warrants that expire on September 21, 2016 with an exercise price of US$0.25. The Company may accelerate the expiry date of the warrants if the stock price trades above CAD$0.40 cents for 20 consecutive days at any time after 6 months and one day has elapsed.
Officer and Directors of Lexaria participated for $48,008 in the above private placement.
“Lexaria thanks its many supporters for their rapid action to close this financing and help enable us to move our Company forward,” said President Chris Bunka. “For many years, Lexaria has been blessed with supportive shareholders who have believed in us and our efforts, and we always recognize that without their support, Lexaria would not be able to build its business and add value today.”
Finders’ fees of 816,000 restricted common shares of the Company were issued, and cash finders’ fees of $16,800 were paid to various brokers.
With this financing completed and funds settled in the bank, Lexaria will endeavor to close its first medical marijuana operations opportunity as quickly as possible. Further announcements will be made as information becomes available.
All issued shares will be subject to a hold period, for any resale into the USA under Rule 144, of six months and one day. Proceeds of the Private Placement will be used for general working capital, for general and administrative needs, and for corporate opportunities in the medical marijuana sector. The Private Placement is subject to normal regulatory approvals.
The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
About Lexaria
Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.
To learn more about Lexaria Corp. visit www.lexariaenergy.com.
FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business will provide any benefit to Lexaria and no assurance that the closed financing will deliver any net benefit to the Company.
The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
Lexaria Corp. – Newest Entrant to $2.4B Medical Marijuana Industry Featured On CEO Interview
Posted by
at 10:44 AM on Thursday, March 20th, 2014
Lexaria Corp. is the newest entrant to the$ 2.4B medical Marijuana Industry. The medical marijuana business just might be one of the most recession-proof industry sectors there are. There is no boom and bust cycle that is apparent. The average demographic age in North America continues to increase, with over 44 million people in the USA today at the age of 65 or over. Age-related illnesses will continue to grow, and some fraction of these people looking for an alternative to opiate-based painkillers have a real need for pain-relief choices.
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
Neah Power’s New BuzzBar Suite is First Recharging Product to Utilize Multiple Sources of Power
Posted by
at 9:11 AM on Thursday, March 20th, 2014
BOTHELL, Wash., March 20, 2014 — Neah Power Systems, Inc., (OTCBB:NPWZ), a provider of proprietary, award-winning, power solutions (protected by patented and patent-pending applications), releases whitepaper regarding unique mobile charging device that can utilize multiple sources of power. The white paper is available for direct download at www.neahpower.com/pdfs/NP-WhitePaper-BuzzCell.pdf, and will help inform consumers about the unique capabilities of the BuzzBar Recharging Suite ahead of the formal launch. It is expected that consumers will be able to begin pre-ordering the new product line on Neah Power’s online store within the next two weeks.
“There are lots of charging devices on the market, but all of them rely on only one source of energy to work,” said Neah Power CEO, Chris D’Couto. “We believe that Neah Power is the first company to bring a revolutionary solution that allows consumers to use multiple sources of power to recharge their mobile devices. The BuzzBar is at the hub of the recharging suite and connects directly to a consumer’s mobile device. The BuzzBar can be recharged using the sun (BuzzSol), AA batteries (BuzzBat), and Neah Power’s exclusive fuel cell liquid power (BuzzCell).”
About Neah Power
Neah Power Systems, Inc., (OTCBB:NPWZ) is an innovator of cutting-edge power solutions for the military, transportation and portable electronics industries. Neah Power’s long-lasting, efficient, and safe solutions include patent-pending micro fuel cells that enable higher power densities in compact form-factors at a lower cost, and that run in aerobic and anaerobic modes. Neah Power was a 2012 ZINO Green Finalist, 2010 WTIA Finalist, and 2010 Best of What’s New Popular Science Award. Contact Neah Power at (425) 424.3324 ext-108 or [email protected]. Neah Power has named Hitman, Inc., as their current agency of record.
Forward Looking Statements
Certain of the statements contained herein may be, within the meaning of the federal securities laws, “forward-looking statements,” which are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, and the Company does not undertake any responsibility to update any of these statements in the future. Please read Neah Power System’s Form 10-K for the fiscal year ended September 30, 2013 and its Quarterly Reports on Form 10-Q filed with the SEC during fiscal 2014 for a discussion of such risks, uncertainties and other factors.
CONTACT: Media Contact:
Heather Bledsoe
Hitman, Inc. | (212) 300.6026
[email protected]